{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T16:36:32Z","timestamp":1773419792643,"version":"3.50.1"},"reference-count":139,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2014,3,1]],"date-time":"2014-03-01T00:00:00Z","timestamp":1393632000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Seminars in Nephrology"],"published-print":{"date-parts":[[2014,3]]},"DOI":"10.1016\/j.semnephrol.2014.02.007","type":"journal-article","created":{"date-parts":[[2014,2,18]],"date-time":"2014-02-18T18:45:23Z","timestamp":1392749123000},"page":"151-163","source":"Crossref","is-referenced-by-count":56,"title":["Laboratory Abnormalities in CKD-MBD: Markers, Predictors, or Mediators of Disease?"],"prefix":"10.1016","volume":"34","author":[{"given":"Pieter","family":"Evenepoel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariano","family":"Rodriguez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Markus","family":"Ketteler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.semnephrol.2014.02.007_bib1","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1080\/07853890701689645","article-title":"Calcium and phosphate homeostasis: concerted interplay of new regulators","volume":"40","author":"Renkema","year":"2008","journal-title":"Ann Med"},{"key":"10.1016\/j.semnephrol.2014.02.007_bib2","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1038\/ki.2011.47","article-title":"Fibroblast growth factor 23 is elevated before parathyroid hormone and phosphate in chronic kidney disease","volume":"79","author":"Isakova","year":"2011","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2014.02.007_bib3","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.2215\/CJN.08241109","article-title":"Fibroblast growth factor-23 in early chronic kidney disease: additional support in favor of a phosphate-centric paradigm for the pathogenesis of secondary hyperparathyroidism","volume":"5","author":"Evenepoel","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2014.02.007_bib4","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1038\/ki.2012.176","article-title":"Update on fibroblast growth factor 23 in chronic kidney disease","volume":"82","author":"Wolf","year":"2012","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2014.02.007_bib5","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1093\/ndt\/gfs050","article-title":"FGF23 and PTH--double agents at the heart of CKD","volume":"27","author":"Silver","year":"2012","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.semnephrol.2014.02.007_bib6","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1093\/ndt\/gfs460","article-title":"Secreted Klotho and FGF23 in chronic kidney disease stage 1 to 5: a sequence suggested from a cross-sectional study","volume":"28","author":"Pavik","year":"2013","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.semnephrol.2014.02.007_bib7","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1038\/ki.1972.84","article-title":"On the prevention of secondary hyperparathyroidism in experimental chronic renal disease using \u201cproportional reduction\u201d of dietary phosphorus intake","volume":"2","author":"Slatopolsky","year":"1972","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2014.02.007_bib8","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1038\/sj.ki.5000414","article-title":"Definition, evaluation, and classification of renal osteodystrophy: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO)","volume":"69","author":"Moe","year":"2006","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2014.02.007_bib9","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1136\/bmj.310.6976.358","article-title":"Effect of alfacalcidol on natural course of renal bone disease in mild to moderate renal failure","volume":"310","author":"Hamdy","year":"1995","journal-title":"Br Med J."},{"key":"10.1016\/j.semnephrol.2014.02.007_bib10","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1159\/000057611","article-title":"Renal osteodystrophy in predialysis and hemodialysis patients: comparison of histologic patterns and diagnostic predictivity of intact PTH","volume":"91","author":"Coen","year":"2002","journal-title":"Nephron"},{"key":"10.1016\/j.semnephrol.2014.02.007_bib11","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1002\/jbmr.309","article-title":"Renal osteodystrophy in the first decade of the new millennium: analysis of 630 bone biopsies in black and white patients","volume":"26","author":"Malluche","year":"2011","journal-title":"J Bone Miner Res"},{"issue":"Suppl 1","key":"10.1016\/j.semnephrol.2014.02.007_bib12","doi-asserted-by":"crossref","first-page":"i9","DOI":"10.1093\/ndt\/gfh1002","article-title":"The importance of bone health in end-stage renal disease: out of the frying pan, into the fire?","volume":"19","author":"Malluche","year":"2004","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.semnephrol.2014.02.007_bib13","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1053\/j.ajkd.2011.04.024","article-title":"Relationship of estimated GFR and coronary artery calcification in the CRIC (Chronic Renal Insufficiency Cohort) study","volume":"58","author":"Budoff","year":"2011","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.semnephrol.2014.02.007_bib14","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1093\/ndt\/gfm660","article-title":"Associations between vascular calcification, arterial stiffness and bone mineral density in chronic kidney disease","volume":"23","author":"Toussaint","year":"2008","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.semnephrol.2014.02.007_bib15","first-page":"S1","article-title":"KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD)","volume":"113","year":"2009","journal-title":"Kidney Int Suppl"},{"key":"10.1016\/j.semnephrol.2014.02.007_bib16","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1038\/ki.2012.403","article-title":"Oral calcium carbonate affects calcium but not phosphorus balance in stage 3-4 chronic kidney disease","volume":"83","author":"Hill","year":"2013","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2014.02.007_bib17","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1038\/ki.2013.21","article-title":"A balanced view of calcium and phosphate homeostasis in chronic kidney disease","volume":"83","author":"Evenepoel","year":"2013","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2014.02.007_bib18","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1053\/ajkd.1998.v31.pm9531176","article-title":"Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients: a national study","volume":"31","author":"Block","year":"1998","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.semnephrol.2014.02.007_bib19","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.1097\/01.ASN.0000133041.27682.A2","article-title":"Mineral metabolism, mortality, and morbidity in maintenance hemodialysis","volume":"15","author":"Block","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2014.02.007_bib20","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1038\/sj.ki.5001514","article-title":"Survival predictability of time-varying indicators of bone disease in maintenance hemodialysis patients","volume":"70","author":"Kalantar-Zadeh","year":"2006","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2014.02.007_bib21","doi-asserted-by":"crossref","first-page":"10e","DOI":"10.1161\/01.RES.87.7.e10","article-title":"Phosphate regulation of vascular smooth muscle cell calcification","volume":"87","author":"Jono","year":"2000","journal-title":"Circ Res"},{"key":"10.1016\/j.semnephrol.2014.02.007_bib22","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1038\/ki.2008.644","article-title":"The emerging role of phosphate in vascular calcification","volume":"75","author":"Giachelli","year":"2009","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2014.02.007_bib23","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1161\/ATVBAHA.108.183384","article-title":"Phosphonoformic acid prevents vascular smooth muscle cell calcification by inhibiting calcium-phosphate deposition","volume":"29","author":"Villa-Bellosta","year":"2009","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.semnephrol.2014.02.007_bib24","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1038\/ki.2011.18","article-title":"Mitochondrial reactive oxygen species promote p65 nuclear translocation mediating high-phosphate-induced vascular calcification in vitro and in vivo","volume":"79","author":"Zhao","year":"2011","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2014.02.007_bib25","doi-asserted-by":"crossref","first-page":"2857","DOI":"10.1097\/01.ASN.0000141960.01035.28","article-title":"Human vascular smooth muscle cells undergo vesicle-mediated calcification in response to changes in extracellular calcium and phosphate concentrations: a potential mechanism for accelerated vascular calcification in ESRD","volume":"15","author":"Reynolds","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2014.02.007_bib26","doi-asserted-by":"crossref","first-page":"e28","DOI":"10.1161\/CIRCRESAHA.108.181305","article-title":"Calcium phosphate crystals induce cell death in human vascular smooth muscle cells: a potential mechanism in atherosclerotic plaque destabilization","volume":"103","author":"Ewence","year":"2008","journal-title":"Circ Res"},{"key":"10.1016\/j.semnephrol.2014.02.007_bib27","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1038\/ki.2010.390","article-title":"Hyperphosphatemia-induced nanocrystals upregulate the expression of bone morphogenetic protein-2 and osteopontin genes in mouse smooth muscle cells in vitro","volume":"79","author":"Sage","year":"2011","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2014.02.007_bib28","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1053\/j.ackd.2010.12.002","article-title":"Direct effects of phosphate on vascular cell function","volume":"18","author":"Lau","year":"2011","journal-title":"Adv Chronic Kidney Dis"},{"key":"10.1016\/j.semnephrol.2014.02.007_bib29","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/ki.2012.300","article-title":"High phosphate directly affects endothelial function by downregulating annexin II","volume":"83","author":"Di Marco","year":"2013","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2014.02.007_bib30","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1038\/nrneph.2013.111","article-title":"Klotho, phosphate and FGF-23 in ageing and disturbed mineral metabolism","volume":"9","author":"Kuro","year":"2013","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.semnephrol.2014.02.007_bib31","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1681\/ASN.2011020175","article-title":"Phosphate may promote CKD progression and attenuate renoprotective effect of ACE inhibition","volume":"22","author":"Zoccali","year":"2011","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2014.02.007_bib32","doi-asserted-by":"crossref","first-page":"883","DOI":"10.2215\/CJN.07810910","article-title":"Chronic kidney disease progression and outcome according to serum phosphorus in mild-to-moderate kidney dysfunction","volume":"6","author":"Bellasi","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2014.02.007_bib33","doi-asserted-by":"crossref","first-page":"2576","DOI":"10.1093\/ndt\/gfq787","article-title":"Serum phosphate but not pulse wave velocity predicts decline in renal function in patients with early chronic kidney disease","volume":"26","author":"Chue","year":"2011","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.semnephrol.2014.02.007_bib34","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1681\/ASN.2012070713","article-title":"Mineral metabolites and CKD progression in African Americans","volume":"24","author":"Scialla","year":"2013","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2014.02.007_bib35","doi-asserted-by":"crossref","first-page":"21","DOI":"10.5414\/CNP71021","article-title":"Efficacy of hyperphosphatemia control in the progression of chronic renal failure and the prevalence of cardiovascular calcification","volume":"71","author":"Lezaic","year":"2009","journal-title":"Clin Nephrol"},{"key":"10.1016\/j.semnephrol.2014.02.007_bib36","doi-asserted-by":"crossref","first-page":"825","DOI":"10.2215\/CJN.02101205","article-title":"Association of disorders in mineral metabolism with progression of chronic kidney disease","volume":"1","author":"Schwarz","year":"2006","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2014.02.007_bib37","doi-asserted-by":"crossref","first-page":"2601","DOI":"10.1681\/ASN.2006080936","article-title":"Fibroblast growth factor 23 (FGF23) predicts progression of chronic kidney disease: the mild to moderate kidney disease (MMKD) study","volume":"18","author":"Fliser","year":"2007","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2014.02.007_bib38","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1038\/ki.1989.281","article-title":"Phosphate excess and progressive renal failure: the precipitation-calcification hypothesis","volume":"36","author":"Lau","year":"1989","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2014.02.007_bib39","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1042\/CS20040048","article-title":"Nephrocalcinosis: molecular insights into calcium precipitation within the kidney","volume":"106","author":"Sayer","year":"2004","journal-title":"Clin Sci"},{"key":"10.1016\/j.semnephrol.2014.02.007_bib40","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1681\/ASN.V1101169","article-title":"Beneficial effects of dietary mineral restriction in dogs with marked reduction of functional renal mass","volume":"1","author":"Brown","year":"1991","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2014.02.007_bib41","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1038\/ki.1986.49","article-title":"Phosphate depletion arrests progression of chronic renal failure independent of protein intake","volume":"29","author":"Lumlertgul","year":"1986","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2014.02.007_bib42","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.1097\/01.ASN.0000025782.24383.0D","article-title":"The effects of sevelamer hydrochloride and calcium carbonate on kidney calcification in uremic rats","volume":"13","author":"Cozzolino","year":"2002","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2014.02.007_bib43","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1046\/j.1523-1755.2003.00284.x","article-title":"Sevelamer hydrochloride attenuates kidney and cardiovascular calcifications in long-term experimental uremia","volume":"64","author":"Cozzolino","year":"2003","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2014.02.007_bib44","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1038\/ki.1980.85","article-title":"Renal toxicity of phosphate in rats","volume":"17","author":"Haut","year":"1980","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2014.02.007_bib45","doi-asserted-by":"crossref","first-page":"519","DOI":"10.2215\/CJN.06080809","article-title":"Understanding sources of dietary phosphorus in the treatment of patients with chronic kidney disease","volume":"5","author":"Kalantar-Zadeh","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2014.02.007_bib46","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.2215\/CJN.03950609","article-title":"Phosphorus additives in food and their effect in dialysis patients","volume":"4","author":"Uribarri","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2014.02.007_bib47","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1001\/jama.2009.96","article-title":"Effect of food additives on hyperphosphatemia among patients with end-stage renal disease: a randomized controlled trial","volume":"301","author":"Sullivan","year":"2009","journal-title":"JAMA"},{"key":"10.1016\/j.semnephrol.2014.02.007_bib48","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1056\/NEJMra0912522","article-title":"Oral phosphate binders in patients with kidney failure","volume":"362","author":"Tonelli","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.semnephrol.2014.02.007_bib49","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1681\/ASN.2008060609","article-title":"Phosphorus binders and survival on hemodialysis","volume":"20","author":"Isakova","year":"2009","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2014.02.007_bib50","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1681\/ASN.2012030223","article-title":"Effects of phosphate binders in moderate CKD","volume":"23","author":"Block","year":"2012","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2014.02.007_bib51","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1159\/000353569","article-title":"Effects of phosphate binder therapy on vascular stiffness in early-stage chronic kidney disease","volume":"38","author":"Seifert","year":"2013","journal-title":"Am J Nephrol"},{"key":"10.1016\/j.semnephrol.2014.02.007_bib52","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1093\/ndt\/gfi268","article-title":"What serum calcium can tell us and what it can\u2019t","volume":"21","author":"Houillier","year":"2006","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.semnephrol.2014.02.007_bib53","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1038\/ki.2011.490","article-title":"Calcium balance in normal individuals and in patients with chronic kidney disease on low- and high-calcium diets","volume":"81","author":"Spiegel","year":"2012","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2014.02.007_bib54","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1038\/ki.2012.33","article-title":"Calcium balance in chronic kidney disease: walking the tightrope","volume":"81","author":"Evenepoel","year":"2012","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2014.02.007_bib55","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.1093\/ndt\/gfq219","article-title":"Serum iPTH, calcium and phosphate, and the risk of mortality in a European haemodialysis population","volume":"26","author":"Floege","year":"2011","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.semnephrol.2014.02.007_bib56","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1056\/NEJM200005183422003","article-title":"Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis","volume":"342","author":"Goodman","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.semnephrol.2014.02.007_bib57","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1681\/ASN.2009060640","article-title":"Chronic mineral dysregulation promotes vascular smooth muscle cell adaptation and extracellular matrix calcification","volume":"21","author":"Shroff","year":"2010","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2014.02.007_bib58","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1016\/S0140-6736(13)60897-1","article-title":"Effect of calcium-based versus non-calcium-based phosphate binders on mortality in patients with chronic kidney disease: an updated systematic review and meta-analysis","volume":"382","author":"Jamal","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.semnephrol.2014.02.007_bib59","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1038\/ki.2013.185","article-title":"Use of phosphate-binding agents is associated with a lower risk of mortality","volume":"84","author":"Cannata-Andia","year":"2013","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2014.02.007_bib60","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1006\/bbrc.2000.4226","article-title":"Severely reduced production of klotho in human chronic renal failure kidney","volume":"280","author":"Koh","year":"2001","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.semnephrol.2014.02.007_bib61","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1681\/ASN.2009121311","article-title":"Klotho deficiency causes vascular calcification in chronic kidney disease","volume":"22","author":"Hu","year":"2011","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2014.02.007_bib62","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1038\/ki.2009.414","article-title":"Depressed expression of Klotho and FGF receptor 1 in hyperplastic parathyroid glands from uremic patients","volume":"77","author":"Komaba","year":"2010","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2014.02.007_bib63","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1097\/MNH.0b013e32835422ad","article-title":"Klotho in health and disease","volume":"21","author":"Kuro-o","year":"2012","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"10.1016\/j.semnephrol.2014.02.007_bib64","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1159\/000324885","article-title":"Indoxyl sulfate downregulates renal expression of Klotho through production of ROS and activation of nuclear factor-kB","volume":"33","author":"Shimizu","year":"2011","journal-title":"Am J Nephrol"},{"key":"10.1016\/j.semnephrol.2014.02.007_bib65","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1038\/ki.2011.445","article-title":"Suppression of Klotho expression by protein-bound uremic toxins is associated with increased DNA methyltransferase expression and DNA hypermethylation","volume":"81","author":"Sun","year":"2012","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2014.02.007_bib66","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.semnephrol.2014.02.004","article-title":"Protein-bound molecules: a large family with a bad character","volume":"34","author":"Sirich","year":"2014","journal-title":"Semin Nephrol"},{"key":"10.1016\/j.semnephrol.2014.02.007_bib67","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1073\/pnas.0902006107","article-title":"Isolated C-terminal tail of FGF23 alleviates hypophosphatemia by inhibiting FGF23-FGFR-Klotho complex formation","volume":"107","author":"Goetz","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.semnephrol.2014.02.007_bib68","doi-asserted-by":"crossref","first-page":"3357","DOI":"10.1210\/jc.2012-1811","article-title":"Biological variability of plasma intact and C-terminal FGF23 measurements","volume":"97","author":"Smith","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.semnephrol.2014.02.007_bib69","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1210\/jc.2009-1603","article-title":"Circulating fibroblast growth factor 23 in patients with end-stage renal disease treated by peritoneal dialysis is intact and biologically active","volume":"95","author":"Shimada","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.semnephrol.2014.02.007_bib70","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1681\/ASN.2010080894","article-title":"Elevated fibroblast growth factor 23 is a risk factor for kidney transplant loss and mortality","volume":"22","author":"Wolf","year":"2011","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2014.02.007_bib71","doi-asserted-by":"crossref","first-page":"2432","DOI":"10.1001\/jama.2011.826","article-title":"Fibroblast growth factor 23 and risks of mortality and end-stage renal disease in patients with chronic kidney disease","volume":"305","author":"Isakova","year":"2011","journal-title":"JAMA"},{"key":"10.1016\/j.semnephrol.2014.02.007_bib72","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1056\/NEJMoa0706130","article-title":"Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis","volume":"359","author":"Gutierrez","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.semnephrol.2014.02.007_bib73","doi-asserted-by":"crossref","first-page":"2792","DOI":"10.1093\/ndt\/gfp191","article-title":"High levels of serum fibroblast growth factor (FGF)-23 are associated with increased mortality in long haemodialysis patients","volume":"24","author":"Jean","year":"2009","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.semnephrol.2014.02.007_bib74","doi-asserted-by":"crossref","first-page":"640","DOI":"10.7326\/0003-4819-152-10-201005180-00004","article-title":"The associations of fibroblast growth factor 23 and uncarboxylated matrix Gla protein with mortality in coronary artery disease: the Heart and Soul Study","volume":"152","author":"Parker","year":"2010","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.semnephrol.2014.02.007_bib75","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1161\/CIRCULATIONAHA.111.053405","article-title":"Vascular klotho deficiency potentiates the development of human artery calcification and mediates resistance to FGF-23","volume":"125","author":"Lim","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.semnephrol.2014.02.007_bib76","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1093\/gerona\/glr058","article-title":"Plasma klotho and mortality risk in older community-dwelling adults","volume":"66","author":"Semba","year":"2011","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"10.1016\/j.semnephrol.2014.02.007_bib77","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1038\/ki.2012.288","article-title":"Plasma Klotho is not related to kidney function and does not predict adverse outcome in patients with chronic kidney disease","volume":"83","author":"Seiler","year":"2013","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2014.02.007_bib78","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1161\/CIRCULATIONAHA.108.844506","article-title":"Fibroblast growth factor 23 and left ventricular hypertrophy in chronic kidney disease","volume":"119","author":"Gutierrez","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.semnephrol.2014.02.007_bib79","doi-asserted-by":"crossref","first-page":"4393","DOI":"10.1172\/JCI46122","article-title":"FGF23 induces left ventricular hypertrophy","volume":"121","author":"Faul","year":"2011","journal-title":"J Clin Invest"},{"key":"10.1016\/j.semnephrol.2014.02.007_bib80","doi-asserted-by":"crossref","first-page":"2688","DOI":"10.1093\/eurheartj\/ehr215","article-title":"The phosphatonin fibroblast growth factor 23 links calcium-phosphate metabolism with left-ventricular dysfunction and atrial fibrillation","volume":"32","author":"Seiler","year":"2011","journal-title":"Eur Heart J"},{"key":"10.1016\/j.semnephrol.2014.02.007_bib81","doi-asserted-by":"crossref","first-page":"2543","DOI":"10.1172\/JCI61405","article-title":"FGF23 neutralization improves chronic kidney disease-associated hyperparathyroidism yet increases mortality","volume":"122","author":"Shalhoub","year":"2012","journal-title":"J Clin Invest"},{"key":"10.1016\/j.semnephrol.2014.02.007_bib82","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1046\/j.1523-1755.2003.00262.x","article-title":"Dynamics of PTH secretion in hemodialysis patients as determined by the intact and whole PTH assays","volume":"64","author":"Santamaria","year":"2003","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2014.02.007_bib83","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1210\/endo-117-1-127","article-title":"Metabolism of radioiodinated carboxy-terminal fragments of bovine parathyroid hormone in normal and anephric rats","volume":"117","author":"D\u2019Amour","year":"1985","journal-title":"Endocrinology"},{"key":"10.1016\/j.semnephrol.2014.02.007_bib84","first-page":"F665","article-title":"Receptors for PTH and PTHrP: their biological importance and functional properties","volume":"277","author":"Mannstadt","year":"1999","journal-title":"Am J Physiol"},{"key":"10.1016\/j.semnephrol.2014.02.007_bib85","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1093\/ndt\/11.7.1292","article-title":"Abnormal calcaemic response to PTH in the uraemic rat without secondary hyperparathyroidism","volume":"11","author":"Berdud","year":"1996","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.semnephrol.2014.02.007_bib86","doi-asserted-by":"crossref","first-page":"2772","DOI":"10.1210\/jc.2009-1909","article-title":"The calcemic response to continuous parathyroid hormone (PTH)(1-34) infusion in end-stage kidney disease varies according to bone turnover: a potential role for PTH(7-84)","volume":"95","author":"Wesseling-Perry","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.semnephrol.2014.02.007_bib87","doi-asserted-by":"crossref","first-page":"357","DOI":"10.7326\/0003-4819-78-3-357","article-title":"Skeletal resistance to parathyroid hormone in renal failure. Studies in 105 human subjects","volume":"78","author":"Massry","year":"1973","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.semnephrol.2014.02.007_bib88","doi-asserted-by":"crossref","first-page":"S34","DOI":"10.1038\/sj.ki.5001600","article-title":"Insufficiency of PTH action on bone in uremia","volume":"102","author":"Iwasaki","year":"2006","journal-title":"Kidney Int Suppl"},{"key":"10.1016\/j.semnephrol.2014.02.007_bib89","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1038\/ki.1995.248","article-title":"Parathyroidectomy does not prevent the renal PTH\/PTHrP receptor down-regulation in uremic rats","volume":"47","author":"Urena","year":"1995","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2014.02.007_bib90","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1046\/j.1523-1755.2000.00306.x","article-title":"Down-regulation of human osteoblast PTH\/PTHrP receptor mRNA in end-stage renal failure","volume":"58","author":"Picton","year":"2000","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2014.02.007_bib91","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.1093\/ndt\/gfh876","article-title":"Downregulation of parathyroid hormone receptor gene expression and osteoblastic dysfunction associated with skeletal resistance to parathyroid hormone in a rat model of renal failure with low turnover bone","volume":"20","author":"Iwasaki-Ishizuka","year":"2005","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.semnephrol.2014.02.007_bib92","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1359\/jbmr.2001.16.3.448","article-title":"Parathyroid hormone\/parathyroid hormone-related peptide type 1 receptor in human bone","volume":"16","author":"Langub","year":"2001","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.semnephrol.2014.02.007_bib93","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1111\/j.1523-1755.2004.00472.x","article-title":"Regulation of PTH1 receptor expression by uremic ultrafiltrate in UMR 106-01 osteoblast-like cells","volume":"65","author":"Disthabanchong","year":"2004","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2014.02.007_bib94","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1038\/sj.ki.5002097","article-title":"Indoxyl sulfate induces skeletal resistance to parathyroid hormone in cultured osteoblastic cells","volume":"71","author":"Nii-Kono","year":"2007","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2014.02.007_bib95","doi-asserted-by":"crossref","first-page":"2815","DOI":"10.1210\/en.2003-1185","article-title":"Ligand-selective dissociation of activation and internalization of the parathyroid hormone (PTH) receptor: conditional efficacy of PTH peptide fragments","volume":"145","author":"Sneddon","year":"2004","journal-title":"Endocrinology"},{"key":"10.1016\/j.semnephrol.2014.02.007_bib96","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1210\/endo.143.1.8575","article-title":"Human PTH-(7-84) inhibits bone resorption in vitro via actions independent of the type 1 PTH\/PTHrP receptor","volume":"143","author":"Divieti","year":"2002","journal-title":"Endocrinology"},{"key":"10.1016\/j.semnephrol.2014.02.007_bib97","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/S0085-2538(15)47156-X","article-title":"A novel mechanism for skeletal resistance in uremia","volume":"58","author":"Slatopolsky","year":"2000","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2014.02.007_bib98","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1210\/endo.142.4.8093","article-title":"Synthetic carboxyl-terminal fragments of parathyroid hormone (PTH) decrease ionized calcium concentration in rats by acting on a receptor different from the PTH\/PTH-related peptide receptor","volume":"142","author":"Nguyen-Yamamoto","year":"2001","journal-title":"Endocrinology"},{"key":"10.1016\/j.semnephrol.2014.02.007_bib99","doi-asserted-by":"crossref","first-page":"1952","DOI":"10.1210\/endo.139.4.5895","article-title":"Conditionally immortalized murine bone marrow stromal cells mediate parathyroid hormone-dependent osteoclastogenesis in vitro","volume":"139","author":"Liu","year":"1998","journal-title":"Endocrinology"},{"key":"10.1016\/j.semnephrol.2014.02.007_bib100","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1111\/j.1525-139X.2009.00659.x","article-title":"Uremic toxicity, oxidative stress, and hemodialysis as renal replacement therapy","volume":"22","author":"Himmelfarb","year":"2009","journal-title":"Semin Dial"},{"key":"10.1016\/j.semnephrol.2014.02.007_bib101","doi-asserted-by":"crossref","first-page":"e40242","DOI":"10.1371\/journal.pone.0040242","article-title":"Measuring parathyroid hormone (PTH) in patients with oxidative stress--do we need a fourth generation parathyroid hormone assay?","volume":"7","author":"Hocher","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.semnephrol.2014.02.007_bib102","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1097\/01.ASN.0000109671.99498.08","article-title":"Successful treatment of an adynamic bone disorder with bone morphogenetic protein-7 in a renal ablation model","volume":"15","author":"Lund","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2014.02.007_bib103","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1146\/annurev.me.37.020186.000443","article-title":"Toxicity of parathyroid hormone in uremia","volume":"37","author":"Klahr","year":"1986","journal-title":"Annu Rev Med"},{"key":"10.1016\/j.semnephrol.2014.02.007_bib104","first-page":"F1","article-title":"Parathyroid hormone metabolism and its potential as a uremic toxin","volume":"239","author":"Slatopolsky","year":"1980","journal-title":"Am J Physiol"},{"key":"10.1016\/j.semnephrol.2014.02.007_bib105","first-page":"13","article-title":"The mechanisms responsible for the PTH-induced rise in cytosolic calcium in various cells are not uniform","volume":"21","author":"Massry","year":"1995","journal-title":"Miner Electrolyte Metab"},{"key":"10.1016\/j.semnephrol.2014.02.007_bib106","first-page":"151","article-title":"Effects of parathyroid hormone on oxidative phosphorylation of heart mitochondria","volume":"7","author":"Bogin","year":"1982","journal-title":"Miner Electrolyte Metab"},{"key":"10.1016\/j.semnephrol.2014.02.007_bib107","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1038\/ki.1985.71","article-title":"Effect of parathyroid hormone on myocardial energy metabolism in the rat","volume":"27","author":"Baczynski","year":"1985","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2014.02.007_bib108","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/S0140-6736(80)90602-9","article-title":"Effect of parathyroidectomy on left-ventricular function in haemodialysis patients","volume":"1","author":"Drueke","year":"1980","journal-title":"Lancet"},{"key":"10.1016\/j.semnephrol.2014.02.007_bib109","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1038\/ki.1987.293","article-title":"Secondary hyperparathyroidism and cardiac hypertrophy in hemodialysis patients","volume":"32","author":"London","year":"1987","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2014.02.007_bib110","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1681\/ASN.V4101814","article-title":"A role of parathyroid hormone for the activation of cardiac fibroblasts in uremia","volume":"4","author":"Amann","year":"1994","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2014.02.007_bib111","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1038\/sj.ki.5002241","article-title":"Vascular calcification: contribution of parathyroid hormone in renal failure","volume":"71","author":"Neves","year":"2007","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2014.02.007_bib112","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1172\/JCI24140","article-title":"Msx2 promotes cardiovascular calcification by activating paracrine Wnt signals","volume":"115","author":"Shao","year":"2005","journal-title":"J Clin Invest"},{"key":"10.1016\/j.semnephrol.2014.02.007_bib113","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1038\/ki.1993.64","article-title":"The spectrum of bone disease in end-stage renal failure--an evolving disorder","volume":"43","author":"Sherrard","year":"1993","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2014.02.007_bib114","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1093\/ndt\/gfq725","article-title":"The ADVANCE study: a randomized study to evaluate the effects of cinacalcet plus low-dose vitamin D on vascular calcification in patients on hemodialysis","volume":"26","author":"Raggi","year":"2011","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.semnephrol.2014.02.007_bib115","doi-asserted-by":"crossref","first-page":"2482","DOI":"10.1056\/NEJMoa1205624","article-title":"Effect of cinacalcet on cardiovascular disease in patients undergoing dialysis","volume":"367","author":"Chertow","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.semnephrol.2014.02.007_bib116","doi-asserted-by":"crossref","DOI":"10.1016\/j.semnephrol.2014.02.008","article-title":"Clinical studies and chronic kidney disease: what did we learn recently?","author":"Liabeuf","year":"2014","journal-title":"Sem Nephrol"},{"key":"10.1016\/j.semnephrol.2014.02.007_bib117","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.abb.2012.04.001","article-title":"Where is the vitamin D receptor?","volume":"523","author":"Wang","year":"2012","journal-title":"Arch Biochem Biophys"},{"key":"10.1016\/j.semnephrol.2014.02.007_bib118","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1038\/ki.2012.273","article-title":"Enhanced induction of Cyp24a1 by FGF23 but low serum 24,25-dihydroxyvitamin D in CKD: implications for therapy","volume":"82","author":"Dusso","year":"2012","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2014.02.007_bib119","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/ki.2010.168","article-title":"Dysregulation of renal vitamin D metabolism in the uremic rat","volume":"78","author":"Helvig","year":"2010","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2014.02.007_bib120","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1038\/ki.2012.222","article-title":"Assessment of 24,25(OH)2D levels does not support FGF23-mediated catabolism of vitamin D metabolites","volume":"82","author":"Dai","year":"2012","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2014.02.007_bib121","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1038\/ki.2012.193","article-title":"The serum 24,25-dihydroxyvitamin D concentration, a marker of vitamin D catabolism, is reduced in chronic kidney disease","volume":"82","author":"Bosworth","year":"2012","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2014.02.007_bib122","doi-asserted-by":"crossref","first-page":"F746","DOI":"10.1152\/ajprenal.1995.268.4.F746","article-title":"Kinetics of monocyte 1 alpha-hydroxylase in renal failure","volume":"268","author":"Gallieni","year":"1995","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.semnephrol.2014.02.007_bib123","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1002\/jbmr.1740","article-title":"Fibroblast growth factor 23 inhibits extrarenal synthesis of 1,25-dihydroxyvitamin D in human monocytes","volume":"28","author":"Bacchetta","year":"2013","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.semnephrol.2014.02.007_bib124","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1159\/000345146","article-title":"Uremia suppresses immune signal-induced CYP27B1 expression in human monocytes","volume":"36","author":"Viaene","year":"2012","journal-title":"Am J Nephrol"},{"key":"10.1016\/j.semnephrol.2014.02.007_bib125","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1172\/JCI118061","article-title":"Inhibition of calcitriol receptor binding to vitamin D response elements by uremic toxins","volume":"96","author":"Patel","year":"1995","journal-title":"J Clin Invest"},{"key":"10.1016\/j.semnephrol.2014.02.007_bib126","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1093\/ndt\/14.1.16","article-title":"Molecular mechanisms of vitamin D hyporesponsiveness in renal failure","volume":"14","author":"Vanholder","year":"1999","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.semnephrol.2014.02.007_bib127","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1681\/ASN.V82271","article-title":"Secondary hyperparathyroidism and vitamin D receptor binding to vitamin D response elements in rats with incipient renal failure","volume":"8","author":"Sawaya","year":"1997","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2014.02.007_bib128","first-page":"182","article-title":"Calciuric response to 1,25-(OH)2D3 in early renal failure","volume":"11","author":"Cremer","year":"1985","journal-title":"Miner Electrolyte Metab"},{"key":"10.1016\/j.semnephrol.2014.02.007_bib129","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1159\/000338299","article-title":"Evidence in favor of a severely impaired net intestinal calcium absorption in patients with (early-stage) chronic kidney disease","volume":"35","author":"Viaene","year":"2012","journal-title":"Am J Nephrol"},{"key":"10.1016\/j.semnephrol.2014.02.007_bib130","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.2215\/CJN.05781207","article-title":"Hypovitaminosis D in chronic kidney disease","volume":"3","author":"Mehrotra","year":"2008","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2014.02.007_bib131","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/ki.2008.501","article-title":"Vitamin D levels and patient outcome in chronic kidney disease","volume":"75","author":"Ravani","year":"2009","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2014.02.007_bib132","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1093\/ndt\/gfq606","article-title":"Vitamin D status and clinical outcomes in incident dialysis patients: results from the NECOSAD study","volume":"26","author":"Drechsler","year":"2011","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.semnephrol.2014.02.007_bib133","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1038\/sj.ki.5002451","article-title":"Vitamin D levels and early mortality among incident hemodialysis patients","volume":"72","author":"Wolf","year":"2007","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2014.02.007_bib134","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1681\/ASN.2004070573","article-title":"Activated injectable vitamin D and hemodialysis survival: a historical cohort study","volume":"16","author":"Teng","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2014.02.007_bib135","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1016\/j.ahj.2012.09.018","article-title":"Vitamin D reduces left atrial volume in patients with left ventricular hypertrophy and chronic kidney disease","volume":"164","author":"Tamez","year":"2012","journal-title":"Am Heart J"},{"key":"10.1016\/j.semnephrol.2014.02.007_bib136","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1016\/S0140-6736(10)61032-X","article-title":"Selective vitamin D receptor activation with paricalcitol for reduction of albuminuria in patients with type 2 diabetes (VITAL study): a randomised controlled trial","volume":"376","author":"de Zeeuw","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.semnephrol.2014.02.007_bib137","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1038\/sj.ki.5002406","article-title":"Differential effects of vitamin D receptor activators on vascular calcification in uremic rats","volume":"72","author":"Mizobuchi","year":"2007","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2014.02.007_bib138","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1038\/sj.ki.5002675","article-title":"The effect of calcitriol, paricalcitol, and a calcimimetic on extraosseous calcifications in uremic rats","volume":"73","author":"Lopez","year":"2007","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2014.02.007_bib139","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1681\/ASN.2007080902","article-title":"Vitamin D receptor activators can protect against vascular calcification","volume":"19","author":"Mathew","year":"2008","journal-title":"J Am Soc Nephrol"}],"container-title":["Seminars in Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S027092951400031X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S027092951400031X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,3,26]],"date-time":"2022-03-26T22:58:25Z","timestamp":1648335505000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S027092951400031X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,3]]},"references-count":139,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,3]]}},"alternative-id":["S027092951400031X"],"URL":"https:\/\/doi.org\/10.1016\/j.semnephrol.2014.02.007","relation":{},"ISSN":["0270-9295"],"issn-type":[{"value":"0270-9295","type":"print"}],"subject":[],"published":{"date-parts":[[2014,3]]}}}